blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability
Register Forum

2022.02.11

More...
blank News flashes

News flashes

New version of the European Patent Register - SPC information for Unitary Patents.

2024-03-06

More...
blank Related links

Release notes
European Patent Register Assistant
European Patent Register Resource Book
European Patent Register – pocket guide
FAQ - European Patent Register
FAQ - Register Alert
Federated Register (Flyer)
Global Dossier (Flyer)
Register events
Deep link coverage
Federated Register content
The Patent Information Tour
Fair use charter

Extract from the Register of European Patents

EP About this file: EP1655036

EP1655036 - METHOD FOR TREATING ONCOLOGICAL DISEASES [Right-click to bookmark this link]
StatusNo opposition filed within time limit
Status updated on  23.05.2014
Database last updated on 15.06.2024
Most recent event   Tooltip15.07.2016Lapse of the patent in a contracting state
New state(s): TR		published on 17.08.2016  [2016/33]
Applicant(s)For all designated states
CLS Therapeutics Limited
Bordeaux Court Les Echelons St Peter Port
Guernsey GY1 3DR / GB
[2011/26]
Former [2006/19]For all designated states
GENKIN, Dmitry Dmitrievich
Konstantinovsky pr., 26-1
St.Petersburg, 197110 / RU
For all designated states
Tets, Viktor Veniaminovich
ul. Lensoveta, 27-95
St. Petersburg, 196066 / RU
Inventor(s)01 / GENKIN, Dmitry Dmitrievich
Konstantinovsky pr., 26-1
St.Petersburg, 197110 / RU
02 / TETS, Viktor Veniaminovich
ul. Lensoveta, 27-95
St.Petersburg, 196066 / RU
03 / TETS, Georgy Viktorovich
ul. Pushkinskaya, d. 13, kv. 41
Saint-Petersburg, 191040 / RU
 [2013/28]
Former [2006/19]01 / GENKIN, Dmitry Dmitrievich
Konstantinovsky pr., 26-1
St.Petersburg, 197110 / RU
02 / TETS, Viktor Veniaminovich
ul. Lensoveta, 27-95
St.Petersburg, 196066 / RU
03 / TETS, Georgy Viktorovich
ul. Pushkinskaya, 13-41
St. Petersburg, 191025 / RU
Representative(s)Gulde & Partner
Patent- und Rechtsanwaltskanzlei mbB
Wallstraße 58/59
10179 Berlin / DE
[2014/19]
Former [2013/29]Schneider, Henry
Anwaltskanzlei Gulde Hengelhaupt Ziebig & Schneider Wallstrasse 58/59
10179 Berlin / DE
Former [2006/19]Schneider, Henry
Anwaltskanzlei Gulde Hengelhaupt Ziebig & Schneider Wallstrasse 58/59
10179 Berlin / DE
Application number, filing date04748955.401.07.2004
[2006/19]
WO2004RU00261
Priority number, dateWO2003RU0030414.07.2003         Original published format: PCT/RU0300/304
RU2004010806112.03.2004         Original published format: RU 2004108061
[2006/19]
Filing languageRU
Procedural languageEN
PublicationType: A1 Application with search report
No.:WO2005004903
Date:20.01.2005
Language:EN
[2005/03]
Type: A1 Application with search report 
No.:EP1655036
Date:10.05.2006
Language:EN
The application published by WIPO in one of the EPO official languages on 20.01.2005 takes the place of the publication of the European patent application.
[2006/19]
Type: B1 Patent specification 
No.:EP1655036
Date:17.07.2013
Language:EN
[2013/29]
Search report(s)International search report - published on:RU20.01.2005
(Supplementary) European search report - dispatched on:EP19.05.2009
ClassificationIPC:A61K38/46, A61P35/00
[2013/04]
CPC:
A61K38/465 (EP,US); A61K9/0019 (EP,US); A61K38/48 (EP,US);
A61P35/00 (EP); A61P43/00 (EP); C07K16/44 (EP,US);
C12Y301/21001 (EP,US); A61K2039/505 (EP,US); A61K2039/53 (EP,US) (-)
C-Set:
A61K38/465, A61K2300/00 (EP,US);
A61K38/48, A61K2300/00 (US,EP)
Former IPC [2006/19]A61K38/43, A61K39/395, A61P35/00
Designated contracting statesAT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HU,   IE,   IT,   LI,   LU,   MC,   NL,   PL,   PT,   RO,   SE,   SI,   SK,   TR [2006/19]
TitleGerman:VERFAHREN ZUR BEHANDLUNG VON ONKOLOGISCHEN ERKRANKUNGEN[2006/19]
English:METHOD FOR TREATING ONCOLOGICAL DISEASES[2006/19]
French:METHODE DE TRAITEMENT DE MALADIES ONCOLOGIQUES[2006/19]
Entry into regional phase14.02.2006Translation filed 
14.02.2006National basic fee paid 
14.02.2006Search fee paid 
14.02.2006Designation fee(s) paid 
14.02.2006Examination fee paid 
Examination procedure11.02.2005Request for preliminary examination filed
International Preliminary Examining Authority: RU
14.02.2006Examination requested  [2006/19]
21.05.2010Despatch of a communication from the examining division (Time limit: M06)
24.11.2010Reply to a communication from the examining division
11.01.2011Despatch of a communication from the examining division (Time limit: M04)
28.02.2011Reply to a communication from the examining division
23.05.2011Despatch of a communication from the examining division (Time limit: M04)
23.09.2011Reply to a communication from the examining division
19.10.2011Despatch of a communication from the examining division (Time limit: M04)
20.01.2012Reply to a communication from the examining division
05.03.2013Communication of intention to grant the patent
06.06.2013Fee for grant paid
06.06.2013Fee for publishing/printing paid
Divisional application(s)The date of the Examining Division's first communication in respect of the earliest application for which a communication has been issued is  21.05.2010
Opposition(s)22.04.2014No opposition filed within time limit [2014/26]
Fees paidRenewal fee
31.07.2006Renewal fee patent year 03
26.07.2007Renewal fee patent year 04
29.07.2008Renewal fee patent year 05
28.01.2010Renewal fee patent year 06
30.07.2010Renewal fee patent year 07
25.07.2011Renewal fee patent year 08
25.07.2012Renewal fee patent year 09
06.06.2013Renewal fee patent year 10
Penalty fee
Additional fee for renewal fee
31.07.200906   M06   Fee paid on   28.01.2010
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court		 See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Lapses during opposition  TooltipHU01.07.2004
AT17.07.2013
BE17.07.2013
BG17.07.2013
CY17.07.2013
CZ17.07.2013
DK17.07.2013
EE17.07.2013
FI17.07.2013
MC17.07.2013
NL17.07.2013
RO17.07.2013
SE17.07.2013
SI17.07.2013
SK17.07.2013
TR17.07.2013
GR18.10.2013
PT18.11.2013
[2016/33]
Former [2016/32]HU01.07.2004
AT17.07.2013
BE17.07.2013
BG17.07.2013
CY17.07.2013
CZ17.07.2013
DK17.07.2013
EE17.07.2013
FI17.07.2013
MC17.07.2013
NL17.07.2013
RO17.07.2013
SE17.07.2013
SI17.07.2013
SK17.07.2013
GR18.10.2013
PT18.11.2013
Former [2016/25]AT17.07.2013
BE17.07.2013
BG17.07.2013
CY17.07.2013
CZ17.07.2013
DK17.07.2013
EE17.07.2013
FI17.07.2013
MC17.07.2013
NL17.07.2013
RO17.07.2013
SE17.07.2013
SI17.07.2013
SK17.07.2013
GR18.10.2013
PT18.11.2013
Former [2016/21]AT17.07.2013
BE17.07.2013
CY17.07.2013
CZ17.07.2013
DK17.07.2013
EE17.07.2013
FI17.07.2013
MC17.07.2013
NL17.07.2013
RO17.07.2013
SE17.07.2013
SI17.07.2013
SK17.07.2013
GR18.10.2013
PT18.11.2013
Former [2014/23]AT17.07.2013
BE17.07.2013
CY17.07.2013
CZ17.07.2013
DK17.07.2013
EE17.07.2013
FI17.07.2013
NL17.07.2013
RO17.07.2013
SE17.07.2013
SI17.07.2013
SK17.07.2013
GR18.10.2013
PT18.11.2013
Former [2014/22]AT17.07.2013
BE17.07.2013
CY17.07.2013
DK17.07.2013
FI17.07.2013
NL17.07.2013
RO17.07.2013
SE17.07.2013
SI17.07.2013
GR18.10.2013
PT18.11.2013
Former [2014/21]AT17.07.2013
BE17.07.2013
CY17.07.2013
DK17.07.2013
FI17.07.2013
NL17.07.2013
SE17.07.2013
SI17.07.2013
GR18.10.2013
PT18.11.2013
Former [2014/18]AT17.07.2013
BE17.07.2013
CY17.07.2013
FI17.07.2013
NL17.07.2013
SE17.07.2013
SI17.07.2013
GR18.10.2013
PT18.11.2013
Former [2014/14]CY10.07.2013
AT17.07.2013
BE17.07.2013
FI17.07.2013
NL17.07.2013
SE17.07.2013
SI17.07.2013
GR18.10.2013
PT18.11.2013
Former [2014/12]CY10.07.2013
AT17.07.2013
BE17.07.2013
FI17.07.2013
SE17.07.2013
SI17.07.2013
GR18.10.2013
PT18.11.2013
Former [2014/11]CY10.07.2013
AT17.07.2013
BE17.07.2013
FI17.07.2013
SE17.07.2013
PT18.11.2013
Former [2014/10]CY10.07.2013
AT17.07.2013
BE17.07.2013
SE17.07.2013
PT18.11.2013
Former [2014/09]AT17.07.2013
BE17.07.2013
SE17.07.2013
PT18.11.2013
Former [2014/08]PT18.11.2013
Documents cited:Search[X]  - SUGIHARA S ET AL, "Deoxyribonuclease treatment prevents blood-borne liver metastasis of cutaneously transplanted tumour cells in mice", BRITISH JOURNAL OF CANCER, NATURE PUBLISHING GROUP, LONDON, GB, (19930101), vol. 67, no. 1, ISSN 0007-0920, pages 66 - 70, XP008086562 [X] 1-9 * see abstract *
International search[Y]US5484589  (SALGANIK RUDOLF I [RU]);
 [A]RU2099080  (FINKO DMITRIJ I [RU], et al);
 [Y]US6521409  (GOCKE CHRISTOPHER D [US], et al);
 [Y]RU2227029  ;
 [Y]  - MUTIRANGURA A., "Serum/plasma viral DNA: mechanism and diagnostic applications to nasopharyngeal and cervical carcinoma", ANN. N. Y. ACAD. SCI., (200109), vol. 945, pages 59 - 67, XP008043289
 [A]  - EL HASSAN N.O. ET AL., "Rescue use of Dnase in critical lung atelectas mucus retention in premature neonates", PEDIATRICS, (200108), vol. 108, no. 2, pages 468 - 470, XP002984504

DOI:   http://dx.doi.org/10.1542/peds.108.2.468
by applicantUS5952170
 US6156504
 US6465177
    - FORTUNE JM; OSHEROFFN., "Chemotherapy, radiotherapy, biotherapy and more recently the immunotherapy are the most-used non-surgical methods of treating of being nice", PROG NUCLEIC ACID RES MOL BIOL, (2000), vol. 64, pages 221 - 53
    - SUGIHARA S. ET AL., British Journal of Cancer, NATURE PUBLISHING GROUP, (19930101), vol. 67, pages 66 - 70
    - P.ANKER ET AL., CLINICA CHIMICA ACTA, (2001), vol. 313, pages 143 - 146
    - FEDOROV N.A., BULL.EXP.BIOL.MED., (1986), vol. 102, pages 281 - 283
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.